BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 23253056)

  • 21. The economic burden of human papillomavirus infection-associated diseases in the Republic of Korea, 2002-2015.
    Ki M; Choi HY; Han M; Oh JK
    Vaccine; 2018 Jul; 36(31):4633-4640. PubMed ID: 29961603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Empirical standard costs for health economic evaluation in Germany -- a proposal by the working group methods in health economic evaluation].
    Krauth C; Hessel F; Hansmeier T; Wasem J; Seitz R; Schweikert B
    Gesundheitswesen; 2005 Oct; 67(10):736-46. PubMed ID: 16235143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P; Whiteford H; Vos T; Bertram M
    J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic burden of injuries in South Korea.
    Lim SJ; Chung WJ; Cho WH
    Inj Prev; 2011 Oct; 17(5):291-6. PubMed ID: 21622932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct and indirect costs associated with Dupuytren's contracture.
    Macaulay D; Ivanova J; Birnbaum H; Sorg R; Skodny P
    J Med Econ; 2012; 15(4):664-71. PubMed ID: 22369346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Health economic impact of viral respiratory infections and pneumonia diseases on the elderly population in Poland].
    Jahnz-Rózyk K
    Pol Merkur Lekarski; 2010 Jul; 29(169):37-40. PubMed ID: 20712246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modeling the cost of influenza: the impact of missing costs of unreported complications and sick leave.
    Xue Y; Kristiansen IS; de Blasio BF
    BMC Public Health; 2010 Nov; 10():724. PubMed ID: 21106057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.
    Syrjänen KJ
    Scand J Infect Dis Suppl; 2009; 107():3-32. PubMed ID: 19408160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hospitalizations associated with malignant neoplasia and in situ carcinoma in the anus and penis in men and women during a 5-year period (2009-2013) in Spain: An epidemiological study.
    López N; Gil-de-Miguel Á; Pascual-García R; Gil-Prieto R
    Hum Vaccin Immunother; 2017 Oct; 13(10):2292-2299. PubMed ID: 28708948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and cost of anal, penile, vaginal and vulvar cancer in Denmark.
    Olsen J; Jørgensen TR; Kofoed K; Larsen HK
    BMC Public Health; 2012 Dec; 12():1082. PubMed ID: 23244352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. National estimates of the inpatient burden of pediatric bipolar disorder in the United States.
    Berry EA; Heaton PT; Kelton CM
    J Ment Health Policy Econ; 2011 Sep; 14(3):115-23. PubMed ID: 22116169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of costs-of-illness in a year before and after inpatient and outpatient rehabilitation in persons with spinal disorders].
    Merkesdal S; Bernitt K; Busche T; Bauer J; Mau W
    Rehabilitation (Stuttg); 2004 Apr; 43(2):83-9. PubMed ID: 15100917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The burden of illness associated with renal cell carcinoma in the United States.
    Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
    Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany.
    Stang A; Stausberg J; Boedeker W; Kerek-Bodden H; Jöckel KH
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):65-72. PubMed ID: 18181975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes--prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany.
    Stock SA; Redaelli M; Wendland G; Civello D; Lauterbach KW
    Diabet Med; 2006 Mar; 23(3):299-305. PubMed ID: 16492214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison.
    Neubauer S; Welte R; Beiche A; Koenig HH; Buesch K; Leidl R
    Tob Control; 2006 Dec; 15(6):464-71. PubMed ID: 17130376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Epidemiology and costs of bronchial asthma and chronic bronchitis in Germany].
    Weissflog D; Matthys H; Virchow JC
    Dtsch Med Wochenschr; 2001 Jul; 126(28-29):803-8. PubMed ID: 11499261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic cost of Guillain-Barré syndrome in the United States.
    Frenzen PD
    Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The economic burden of gout on an employed population.
    Brook RA; Kleinman NL; Patel PA; Melkonian AK; Brizee TJ; Smeeding JE; Joseph-Ridge N
    Curr Med Res Opin; 2006 Jul; 22(7):1381-9. PubMed ID: 16834837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.